St. Lukes Cancer Institute /ID# 118775 — Kansas City, Missouri

St. Lukes Cancer Institute /ID# 118775 is a clinical research site located in Kansas City, Missouri, United States 64111-5905.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

St. Lukes Cancer Institute /ID# 118775 has participated in 1 clinical trials.

Therapeutic areas: Triple Negative Breast Cancer.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for St. Lukes Cancer Institute /ID# 118775?

St. Lukes Cancer Institute /ID# 118775 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has St. Lukes Cancer Institute /ID# 118775 conducted?

St. Lukes Cancer Institute /ID# 118775 has 1 clinical trials on record. Their work covers Triple Negative Breast Cancer.

Is St. Lukes Cancer Institute /ID# 118775 accredited by Crixeo Health?

St. Lukes Cancer Institute /ID# 118775 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about St. Lukes Cancer Institute /ID# 118775?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.